Perspective
Published on 27 Nov 2024
The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488725
Type at least 3 characters
396 articles
Articles
Original Research
Accepted on 26 Nov 2024
Ophthalmic Corticosteroids-related adverse events: The FDA Adverse Event Reporting System Database (FAERS) Database pharmacovigilance study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1502047
Original Research
Accepted on 26 Nov 2024
Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1412743
Original Research
Accepted on 22 Nov 2024
Global research trends in therapeutic drug monitoring of antimicrobials from 2000 to 2023: A bibliometric analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1474878
Original Research
Published on 22 Nov 2024
Drug-induced hearing disorders: a disproportionality analysis of the FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1480994
- 178 views
Original Research
Published on 21 Nov 2024
Using machine learning to identify risk factors for pancreatic cancer: a retrospective cohort study of real-world data
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1510220
- 296 views
Systematic Review
Published on 21 Nov 2024
Efficacy of combination therapy of vitamin D and bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and meta-analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1422062
- 194 views
Original Research
Accepted on 20 Nov 2024
Spontaneous Adverse Drug Reactions Reported in A Thirteen-Year Pharmacovigilance Program in A Tertiary University Hospital
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1427772
Original Research
Accepted on 19 Nov 2024
Drug-Induced Retinal Vein Occlusion: A Disproportionality Analysis From the FDA Adverse Event Reporting System (2004-2023)
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1480269
Original Research
Accepted on 18 Nov 2024
A Real-World Pharmacovigilance Study of Neuroleptic Malignant Syndrome Based on FDA Adverse Event Reporting System
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1438661
Original Research
Published on 15 Nov 2024
Association between blood lead and periodontitis among American adults: a cross-sectional study of the national health and nutrition examination survey
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1420613
- 158 views
Original Research
Published on 14 Nov 2024
Monitoring vancomycin blood concentrations reduces mortality risk in critically ill patients: a retrospective cohort study using the MIMIC-IV database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1458600
- 468 views
Original Research
Published on 13 Nov 2024
Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1458500
- 342 views
Original Research
Accepted on 12 Nov 2024
Use of fluoroquinolones and risk of rhegmatogenous retinal detachment: a retrospective cohort study using two nationwide representative claims databases
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1414221
Original Research
Published on 12 Nov 2024
Trends of antiseizure medication utilization among pregnant people in four Canadian provinces from 1998 to 2023; a study from the Canadian mother-child cohort active surveillance initiative (CAMCCO)
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1469552
- 465 views
Systematic Review
Published on 12 Nov 2024
Efficacy and safety of complement inhibitors in patients with geographic atrophy associated with age-related macular degeneration: a network meta-analysis of randomized controlled trials
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1410172
- 189 views